Biotricity Total Long Term Liabilities 2015-2024 | BTCY
Biotricity total long term liabilities from 2015 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
| Biotricity Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $15 |
| 2023 | $15 |
| 2022 | $14 |
| 2021 | $1 |
| 2020 | $1 |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| 2015 | $0 |
| 2015 | $ |
| 2014 | $0 |
| 2014 | $ |
| Biotricity Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $15 |
| 2024-03-31 | $15 |
| 2023-12-31 | $15 |
| 2023-09-30 | $16 |
| 2023-06-30 | $14 |
| 2023-03-31 | $15 |
| 2022-12-31 | $15 |
| 2022-09-30 | $14 |
| 2022-06-30 | $14 |
| 2022-03-31 | $14 |
| 2021-12-31 | $14 |
| 2021-09-30 | $1 |
| 2021-06-30 | $1 |
| 2021-03-31 | $1 |
| 2020-12-31 | $7 |
| 2020-09-30 | $2 |
| 2020-06-30 | $3 |
| 2020-03-31 | $1 |
| 2019-12-31 | $1 |
| 2019-09-30 | $0 |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2014-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.008B | $0.012B |
| Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $10.506B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.928B | 153.33 |
| Inspire Medical Systems (INSP) | United States | $5.459B | 170.26 |
| Axonics (AXNX) | United States | $3.601B | 1761.25 |
| IRhythm Technologies (IRTC) | United States | $2.727B | 0.00 |
| Privia Health (PRVA) | United States | $2.621B | 218.40 |
| Enovis (ENOV) | United States | $2.595B | 17.59 |
| Omnicell (OMCL) | United States | $2.214B | 72.44 |
| Azenta (AZTA) | United States | $2.177B | 108.56 |
| 10x Genomics (TXG) | United States | $1.805B | 0.00 |
| Schrodinger (SDGR) | United States | $1.608B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.572B | 0.00 |
| Phreesia (PHR) | United States | $1.292B | 0.00 |
| Standard BioTools (LAB) | United States | $0.685B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.567B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.557B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.527B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.522B | 90.40 |
| Pulmonx (LUNG) | United States | $0.265B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.239B | 0.00 |
| TruBridge (TBRG) | United States | $0.236B | 68.65 |
| American Well (AMWL) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.105B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.089B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.058B | 0.00 |
| Outset Medical (OM) | United States | $0.047B | 0.00 |
| Zepp Health (ZEPP) | China | $0.047B | 0.00 |
| CareCloud (CCLD) | United States | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.039B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.021B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |